MVC Blog -

18 Dec 2024

Reflecting on Successes in 2024 and Looking Ahead to 2025

December 18, 2024 | 0 Comments | celebrations, MVC Coordinating Center

Over the years, it’s become somewhat of a tradition for me to use our final blog of the year to step back and reflect on what we have achieved together over the last 12 months, as well as look ahead to all the exciting things in the pipeline for 2025. December has well and truly snuck up on us but what a year it’s been.

In 2024, MVC’s engagement with our 105 hospital and 33 physician organization members reached new heights. During this time, we held two flagship collaborative-wide meetings and delivered 22 virtual workgroups, incorporating 33 different member presentations as part of these events to foster continued information and best practice sharing. It’s therefore no surprise that are our average attendance numbers at each of these engagement touchpoints were far above previous years.

Our new cardiac rehab pages and other registry developments also led to a rise in the number of people accessing our online platform, with a total of 121 new registry users over the course of 2024. These new registry pages have helped increase engagement with MVC’s cardiac rehab value improvement initiative and we just launched similar pages for our preoperative testing initiative. MVC’s data analytic offerings continue to go from strength to strength as well, with 18 different sites taking advantage of MVC’s one-on-one custom analytic reports and all hospital members continuing to benefit from MVC’s refreshed suite of push reports.

The MVC Component of the BCBSM P4P Program kept us busy this year too, with end-of-year scorecards for PY23, mid-year scorecards for PY24, and program selections for PY26/27. In looking at PY26/27 in particular, the Coordinating Center worked in partnership with members and the BCBSM Hospital P4P Quarterly workgroup to develop and implement a number of changes for this future program cycle. As MVC continues to ensure that this program is truly representative of the patient populations that members serve, Michigan Medicaid will be added to the program come 2026. This represents a big win and means the MVC Component is now inclusive of all MVC data sources. Elsewhere, changes have been made to MVC’s episode condition and value metrics menus, and a new health equity measure has been introduced. We’re pretty excited about this new addition in particular so please feel free to reach out if you want to get in the weeds and learn more.

In addition to all this great work, a personal highlight of mine has been the continued evolution of the MVC Coordinating Center and more specifically, the continued growth of those people that make it such an enjoyable place to work. We have welcomed a few new faces to our team this year and with fresh eyes comes fresh perspectives; we’re excited to leverage these insights as we move into 2025. Speaking of which, we have a number of new developments for the coming year that I’m excited to be able to share with you.

New Preoperative Testing Registry Pages

In June of this year, we launched four new multi-payer reports on our online registry. These reports evaluate cardiac rehabilitation utilization and encompass all metrics previously provided annually in MVC’s hospital-level cardiac rehab push report for acute myocardial infarction (AMI), percutaneous coronary intervention (PCI), heart valve repair or replacement (SAVR or TAVR), coronary artery bypass graft (CABG), and congestive heart failure (CHF).

Following the success of these multi-payer registry reports, we worked to add equivalent pages for MVC’s preoperative testing measures. Those registry pages went live on our registry at the end of last week, and will allow members to select specific preoperative conditions and payers, customize date ranges, and filter by patient characteristics. MVC will hold educational webinars in January to help increase familiarity and improve user experience with these new multi-payer reports.

New MVC Component of the BCBSM P4P Program PY26/27 Registry Pages

Another addition to the MVC registry in 2025 will see new P4P pages added to reflect the recent changes shared for PY26/27. While these pages will look and feel very similar to those currently available for PY24/25, the main update here will be the launch of a dedicated page for MVC’s new health equity measure. We understand the importance of making sure that members have time to become familiar with this new part of the MVC Component; therefore, in addition to reporting on it for informational purposes in 2025 P4P scorecards, this new page will be live for member use towards the end of Q2.

MVC Push Reports and Custom Analytics

MVC’s suite of push reports will continue to be refreshed throughout 2025 and, in response to member requests, we will launch a new quarterly push report calendar. This is designed to inform members of which reports will be delivered when and therefore help strengthen internal organizational planning. As mentioned above, MVC has seen great engagement this year relative to our custom analytics, and we will be looking to share examples of such outputs with the collaborative in 2025 to increase awareness of their value and possible scope.

Updates to MVC’s Suite of Virtual Workgroups

In response to member feedback and recent surveys, MVC’s schedule for virtual workgroups has been updated for 2025. Over the course of next year, members will be able to hear directly from peers and the Coordinating Center on the following topic areas: cardiac rehabilitation, health in action (ad hoc topics), preoperative testing, post-discharge follow-up, rural health, and sepsis. More information can be found here.

Site and System-Level Visits

Over the course of 2024, the Coordinating Center conducted a number of virtual and in-person site visits, both at individual sites and in partnership with systems. These visits are designed to provide members with a more in-depth understanding of MVC and its offerings, as well as providing an opportunity for the Coordinating Center to strengthen its understanding of member activities, priorities, and system-level practices. Sites are able to earn P4P engagement points for participating in such visits; if you are interested in getting on the calendar for 2025, please don’t hesitate to reach out.

Thank you again for your continued partnership throughout the last year and we look forward to more successes in 2025. Have a great holiday and a happy new year when it rolls around.

04 Dec 2024

Cardiac Rehab Michigan Cardiac Rehabilitation Network MVC workgroup preoperative testing rite-size

View Post

November Workgroups Highlight Preop Testing Project and Cardiac Rehab Access Initiative

December 4, 2024 | 0 Comments | Cardiac Rehab, Michigan Cardiac Rehabilitation Network, MVC workgroup, preoperative testing, rite-size

In November, MVC hosted two virtual workgroup presentations – the first on preoperative testing was led by a fellow Collaborative Quality Initiative (CQI), and the second on cardiac rehabilitation was delivered by an MVC member hospital. MVC hosts two virtual workgroups per month with topics rotating between post-discharge follow-up, sepsis, cardiac rehabilitation, rural health, preoperative testing, and health in action (ad hoc focused topics). Each month, the MVC Coordinating Center publishes key highlights from these presentations to support resource and best practice sharing across the state.

November Preoperative Testing Workgroup: Michigan Surgical Quality Collaborative (MSQC)

The first workgroup of November focused on preoperative testing and featured a presentation by Pamela Racchi, Clinical Site Coordinator with the Michigan Surgical Quality Collaborative (MSQC), and Susanna Fortney, Clinical Quality Specialist at ProMedica Charles and Virginia Hickman Hospital. To start, Racchi’s presentation provided an update on MSQC’s Preoperative Testing for Low-Risk Surgeries Project, including updated findings for 2024 and plans for 2025. Fortney then presented on ProMedica Charles and Virginia Hickman’s progress with reducing preoperative testing through the lens of participating in both the MSQC preop testing project and the RITE-Size pilot.

MSQC’s preoperative testing project is a continuation of a pilot started in 2022. The goals of the project include:

To define the extent of routine preoperative testing in low-risk surgeries,
To identify underlying reasons for overuse of preoperative testing in low-risk surgeries, and
To implement interventions to heighten awareness and reduce variation among hospitals

Their project varies slightly from MVC’s preoperative testing offerings in that MSQC includes a slightly broader range of low-risk surgeries. The MSQC preop testing project includes abstraction for cases of minor hernia (abdominal hernias <3 cm and all inguinal/ femoral hernia repairs), laparoscopic cholecystectomy, and breast lumpectomy.

During the pilot, MSQC included all ASA classes in their analysis. Based on feedback from site participants, however, MSQC has since limited their evaluated cases to only ASA class I and II, elective cases, and low-risk surgeries identified as the intended primary procedure (based on CPT codes) for 2024. Patients falling into ASA classes I and II are expected to be stable with their comorbid conditions and therefore require less frequent testing.

Overall, results since September 2024 suggest ASA I and II cases are all trending in the right direction; abstracted data currently indicates preop testing rates of 18% among ASA I cases (with a goal of 25% or less) and 31% among ASA II cases (with a goal of 32% or less), as shown in Figure 1.

Racchi also noted that the success of reducing preoperative testing is dependent on there being no further increases in unnecessary testing on the day of surgery. Historically, MSQC has calculated preoperative testing rates like MVC, up to 30 days prior to a surgery but not including the day of surgery. However, MSQC’s abstractors can additionally identify testing completed on the day of surgery. In 2024, MSQC abstractors are assessing cases that received testing on the day of surgery as well as those that received testing in the 30 days prior to a surgery. Preliminary performance results suggested there was an increase in day of preoperative testing when compared to baseline for both ASA I and II cases. Racchi noted that these analyses help determine whether testing was clinically necessary versus a result of physician habit.

Racchi and Fortney both spoke to the benefits of increasing engagement between surgery and anesthesiology to streamline preoperative testing protocols and processes. Between 2022 and 2023, ProMedica Charles and Virginia Hickman was able to reduce their preoperative testing rate by nearly 20% with just a few modifications to their testing protocol and additional onboarding of the anesthesiology providers.

A recent review of preoperative testing cases at ProMedica Hickman that were labeled unnecessary revealed nearly 40% were, in fact, medically justified and another 42% were due to protocol misinterpretation. Interestingly, the greatest rate of unnecessary preoperative testing was found to derive from ProMedica Hickman’s preadmission testing department. Fortney noted they had success embedding an adapted version of the RITE-Size program’s decision aid (Figure 2) within their anesthesiology preoperative protocols, and this helped to provide a more robust visual for their providers to reference when completing preop documentation.

ProMedica Hickman additionally implemented a process for one-on-one training with preadmission testing (PAT) nursing staff, re-education, and the inclusion of case studies. The PAT nurses have also been included in MSQC/RITE-Size project update meetings and are given access to push reports so they can better understand their progress and impact.

The RITE-Size project is a collaboration between several CQI organizations – the Michigan Program on Value Enhancement (MPrOVE), the Michigan Value Collaborative (MVC), MSQC, and the Anesthesiology Performance Improvement and Reporting Exchange (ASPIRE). Each organization has individual projects underway to address unnecessary preoperative testing, but also collaborate under the umbrella of RITE-Size to support de-implementation with additional customized support and coaching. Learn more about RITE-Size by visiting the program website here.

November Cardiac Rehab Workgroup: Marshfield Medical Center – Dickinson

The second November workgroup focused on cardiac rehabilitation – another of MVC’s value-based initiatives. This workgroup featured a joint presentation by Carolyn Hoy, BSN, Director of Quality; Courtney Swanson, BSN, RN, Heart Care Clinic and Cardiopulmonary Rehab Manager; and Lacey Schjoth, BS, Cardiac Rehab Coordinator at Marshfield Medical Center – Dickinson. Hoy, Swanson, and Schjoth’s presentation introduced Marshfield – Dickinson’s cardiac rehab Patient Access Improvement Project, an initiative rooted in one of their core values of patient-centered care.

Although part of a much larger system, Marshfield Medical Center – Dickinson is a relatively small hospital with about 49 general med/surgical beds. To support a significantly rural population in the Upper Peninsula, the Marshfield – Dickinson team identified the need to modify their cardiac rehab program to improve access. Their three main goals included:

Increase the volume of patients seen,
Accurately track referrals,
Expand services to include a supervised exercise therapy (SET) peripheral artery disease (PAD) program

Swanson and Schjoth described how the Northern Michigan landscape and weather contributed to some of the barriers patients faced in accessing cardiac rehab care. Outside of Marshfield – Dickinson’s cardiac rehab center, the next rehabilitation facility is nearly 45 miles away. To support patients driving a long distance to receive cardiac rehab, the team worked to coordinate with their patient’s other appointments. They also flexed their schedules to accommodate earlier or later availability and were willing to shift the appointment times as needed pending weather conditions.

Ultimately, the team was able to increase their class size to five patients per class and increased their class offerings by one cardiac rehab (and one pulmonary rehab) class per day by December 2023. They saw a nearly 27% increase in patient enrollment between 2022 and 2023 (Figure 3). Thus far in 2024, their patient volumes are on track to match or exceed 2023.

Since Marshfield – Dickinson is unable to support a Phase 1 cardiac rehab program, most of their referrals come from outside facilities located in Wisconsin. Connecting with patients quickly after referrals are received is helpful to reduce the duration of time between referral and enrollment. With adjustments to their workflow, the team was able to reduce the average time from referral to initial contact to an average of just 3.5 days as of November 2024. The team also observed a corresponding reduction in the time to first cardiac rehab visit of just 16.5 days on average.

However, rectifying referral documentation from multiple outside sources can slow down this process. Additionally, surveyed patients reported that one of the largest barriers to starting cardiac rehab was a lack of insurance coverage or high copays, with nearly 9% of patients identifying this as the primary reason they did not schedule their initial cardiac rehab appointment in 2024. The team has recently brought on a financial counselor to assist in contacting insurance companies and ensuring adequate and accurate referrals documentation.

Lastly, the Marshfield – Dickinson cardiac rehab team worked to develop close partnerships with local cardiology providers. Ensuring local cardiology providers are aware of and supportive of cardiac rehab is a critical step that generates additional opportunities for program endorsement and patient education by the provider. Marshfield – Dickinson has additionally added Dr. Massabni, an interventional cardiologist specializing in peripheral artery disease, to their staff. This allowed them to further develop their SET PAD program in January 2024 and they are seeing increasing enrollment in this specialized vascular program.

Much of MVC’s work with its members and partners in the space of cardiac rehab is delivered under the umbrella of the Michigan Cardiac Rehab network (MiCR), a collaborative partnership with the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). You can see the MiCR website and offerings here. MVC also offers a robust registry of medical insurance claims data and data specialists that can help navigate and create custom analytic reports on cardiac rehab utilization metrics. Please reach out to the Coordinating Center by email if you would like to learn more about MVC data or engagement offerings.

To learn more about the efforts showcased by November’s workgroup presenters, or other past workgroup presentations, please visit MVC’s YouTube Channel here.

December’s workgroups will feature a post-discharge follow-up presentation on December 3 led by Crystal Young of Corewell Health Trenton and Natalie Holland of MDHHS. Additionally, on December 12, Toni Moriarty-Smith of McLaren Northern Michigan will present a rural health presentation. The complete 2024 and 2025 MVC event calendars and workgroup registration links are available here.

20 Nov 2024

diabetes mct2d MVC report Type 2 diabetes

View Post

Diabetes Awareness Month: MVC Highlights MCT2D Collaborations to Improve Diabetes Care

November 20, 2024 | 0 Comments | diabetes, mct2d, MVC report, Type 2 diabetes

November is Diabetes Awareness Month, a time to bring attention to the growing prevalence and impact of diabetes as well as the importance of early diagnosis, effective management, and prevention. According to the CDC, diabetes is a leading cause of morbidity and mortality in the United States, affecting vital organs such as the nervous system, kidneys, heart, and eyes. In 2021, it was estimated that 38.4 million people of all ages had diabetes—more than 1 in 9 adults in Michigan alone—a number that continues to rise globally. Additionally, recent studies show that 98 million American adults have prediabetes, putting them at high risk for developing Type 2 diabetes (T2D). The need for increased awareness and proactive care has never been more urgent.

Despite being one of the most prevalent chronic conditions worldwide, T2D is largely preventable. Given its chronic nature, it is essential to advocate for widespread access to patient resources, leverage data analytics to pinpoint areas for improvement, and ensure that all individuals across Michigan have the opportunity to access care that can prevent the disease from progressing.

MVC Offerings for T2D Care

MVC is committed to using claims-based data to improve the health of Michigan through sustainable, high-value healthcare. Recently, MVC expanded its focus to address T2D and its complications. In March 2024, MVC incorporated two high-volume emergency department (ED) conditions into its new ED-based episodes: diabetes with long-term complications (e.g., renal, eye, neurological, and circulatory issues) and short-term complications (e.g., ketoacidosis, hyperosmolarity, or coma). These ED-based episodes were developed in partnership with MEDIC and can be used to generate custom analytics for any MVC hospital or physician organization member.

MVC also has ongoing collaborations with the Michigan Collaborative for Type 2 Diabetes (MCT2D) to identify opportunities to improve care for T2D patients and evaluate the impact of CQI initiatives. Currently, both teams are partnering on a value exercise to assess whether practices participating in MCT2D reduced the use of certain diabetes medications compared to non-participating sites. This work will provide valuable insights into medication utilization.

More recently, MVC’s collaboration with MCT2D led to the creation of a new report on T2D in Michigan. It provided demographics and analyses for patients with T2D in Michigan insured by Blue Cross Blue Shield of Michigan (BCBSM), Blue Care Network (BCN), Medicare Fee-for-Service (FFS), and Michigan Medicaid between 2017 and 2023. The report also integrated pharmacy prescription claims. The report showcased several key trends, including:

A notable decrease in ED utilization and hospitalizations for T2D care from 2017-2023 (Figure 1).
An increase in visits with primary care providers (PCPs) and specialists, such as endocrinologists and nephrologists (Figure 2).
A shift in prescription utilization, with increased use of newer medications like GLP-1 receptor agonists and SGLT2 inhibitors, while the use of older therapies such as insulin and sulfonylureas declined (Figure 3).

The report also highlighted important demographic trends, including that T2D patients in Michigan are, on average, older, more likely to be male, and more likely to be Black, with a higher prevalence of non-commercial insurance coverage. These insights are helping MVC and MCT2D to focus their future efforts.

Looking Towards the Future

Although the prevalence of diabetes is a significant challenge, the innovative efforts of groups such as MCT2D and the American Diabetes Association provide hope for the future. MVC is excited to complete and share its value exercise with MCT2D in 2025, as well as continue to build on its offerings to MVC member hospitals and physician organizations for diabetes-related improvement projects.

Diabetes Awareness Month offers an opportunity to reflect on the challenges faced by millions living with diabetes, while also recognizing the significant progress being made in the fight against the disease. With the continued support of healthcare professionals, organizations, and communities, MVC is committed to improving care, prevention, and education. Together, we can raise awareness, improve outcomes, and provide support for those affected by diabetes.

13 Nov 2024

MVC P4P

View Post

PY 2026-2027 Selection Reports Sent for MVC Component of BCBSM P4P Program

November 13, 2024 | 0 Comments | MVC P4P

Beginning in 2018, Blue Cross Blue Shield of Michigan (BCBSM) allocated 10% of its Pay-For-Performance (P4P) program to a metric based on Michigan Value Collaborative (MVC) claims data. In 2024, the BCBSM P4P Quarterly Workgroup approved changes to how hospitals will be evaluated in the upcoming two-year cycle for Program Years (PYs) 2026 and 2027. These program years will use claims data from 2025 and 2026, respectively, for the performance years (Figure 1). Hospitals recently received selection reports to aid in their decision-making on which metrics to choose within the new program structure.

What is staying the same from PYs 2024-2025?

Similar to the PY 2024-2025 cycle, hospitals will continue to be scored out of 10 points maximum. They will also continue to be evaluated on their risk-adjusted, price-standardized total episode spending for a selected condition; their rate for a selected value metric; and their engagement in MVC activities. Hospitals can continue to select coronary artery bypass graft (CABG), congestive heart failure (CHF), or chronic obstructive pulmonary disorder (COPD) for episode spending scoring. Similarly, most of the value metric options remain the same with changes in definition for only the preoperative testing and sepsis value metrics.

Each hospital’s episode spending and value metric selections will continue to be scored on improvement compared to the hospital’s own past performance as well as on achievement relative to an MVC cohort. Each hospital will continue to be awarded the greater of the two scores, either improvement or achievement, which are calculated using Z-scores. Cohort designation is still based on bed size, critical access status, and case mix index.

What is changing for PYs 2026-2027?

While the overall program structure will be scored to a maximum of 10 points (Figure 2), the scoring within the components varies from PY 2024-2025. The PY 2026-2027 cycle is made up of a maximum of three points from an episode spending metric, a maximum of four points from a value metric, a maximum of two points from engagement activities, and a maximum of one point from a health equity measure (a new component). For this cycle, hospitals will need to select an episode spending condition and a value metric. The health equity and engagement activities do not require selection. Eligibility for selections are determined based on case counts. To be eligible to select a condition or value metric, a hospital must have at least 20 cases in the full baseline year of 2023.

Although three episode spending conditions offered in PYs 2024-2025 will continue to be options in PYs 2026-2027 (i.e., CABG, CHF, COPD), MVC retired colectomy (non-cancer), joint replacement, and pneumonia from its episode spending menu. In addition, MVC is adding percutaneous coronary intervention (PCI) as an episode spending condition. The full menu of episode spending conditions for PYs 2026-2027 will be CABG, CHF, COPD, and PCI.

MVC is also modifying two of its value metrics. The sepsis value metric in PYs 2026-2027 will be 14-day follow-up after sepsis rather than 30-day risk-adjusted readmissions after sepsis. This change is more closely aligned with the HMS incentive for increasing post-discharge care coordination. The preoperative testing value metric definition will also be different in PYs 2026-2027. The first change is that all three included procedures (i.e., laparoscopic cholecystectomy, inguinal hernia repair, and lumpectomy) will be combined for scoring. Previously, each procedure was treated separately, and hospitals were scored on the best of the three. The second change is that lab testing will be included in the definition. Previously, preoperative lab tests such as complete blood count, metabolic panel, coagulation studies, and urinalysis were not included in calculating the testing rate prior to the three procedures. Going forward, MVC will identify preoperative testing that occurs in the 30 days prior to MVC-defined laparoscopic cholecystectomy, inguinal hernia repair, and lumpectomy for any of the following tests: complete blood count, basic metabolic panel, comprehensive metabolic panel, coagulation studies, electrocardiogram, echocardiogram, cardiac stress test, chest x-ray, pulmonary function test, and urinalysis.

Brand new in PY 2026-2027 will be the addition of a claims-based health equity measure, for which hospitals will be assessed using an index of disparity (Figure 3). The index of disparity (IOD) will measure the spread of 30-day risk-adjusted all cause readmission rates for medical conditions among different payer categories within their hospital. Scoring for this measure will begin in PY 2026, but hospitals will begin to see sample scoring for this measure on their PY 2025 scorecards. Hospitals can earn the health equity point through both improvement and achievement pathways, similar to their episode spending and value metric selections.

The payer mix for PYs 2026-2027 will now include Michigan Medicaid episodes in addition to the previously included BCBSM Preferred Provider Organization (PPO) Commercial, BCBSM PPO Medicare Advantage, Blue Care Network (BCN) Health Maintenance Organization (HMO) Commercial, BCN HMO Medicare Advantage, and Medicare FFS coverage. The addition of Medicaid takes the MVC Component of the BCBSM P4P Program closer to a more diverse and representative population. Medicaid data are reflected in the baseline measures provided in the PY 2026-2027 selection reports.

Next Steps for PY 2026-2027 Selections

The P4P selection reports distributed earlier this week include tables for the various episode spending and value metric options, identifying case counts in the baseline year, the hospital’s average payment or rate of utilization, the cohort and MVC All average payments or rates, and the projected changes necessary for the hospital to earn maximum points. Accompanying the reports was a health equity measure document that details the methodology behind this newly introduced measure along with scoring examples.

For a detailed summary on the methodology, please refer to the PY 2026-2027 P4P Technical Document on the MVC P4P webpage. MVC has also developed an FAQ document to answer some of the mostly frequently asked questions regarding PY 2026-2027 changes, and is offering webinars on Nov. 19 at 1 p.m. [register here] and Nov. 21 at 10 a.m. [register here] to answer member questions. Member hospitals should submit their PY 2026-2027 selections by December 13, 2024, using this Qualtrics survey. Please contact the MVC Coordinating Center if you have any questions.

06 Nov 2024

hospital care at home MVC workgroup sepsis

View Post

October MVC Workgroups Highlight Hospital Care at Home and Sepsis Compliance Work

November 6, 2024 | 0 Comments | hospital care at home, MVC workgroup, sepsis

Last month, MVC hosted virtual presentations for a health in action workgroup as well as a sepsis workgroup. MVC hosts two virtual workgroups per month with topics rotating between post-discharge follow-up, sepsis, cardiac rehabilitation, rural health, preoperative testing, and health in action (ad hoc focused topics). Each month, the MVC Coordinating Center publishes key highlights from these presentations to support resource sharing and collaboration across the state.

October Health in Action Workgroup: University of Michigan Health

In early October, MVC’s health in action workgroup focused on Hospital Care at Home (HCAH) and featured a presentation by Jessie DeVito, Administrative Director of HCAH at University of Michigan Health. DeVito’s presentation reviewed University of Michigan Health’s HCAH program from inception in 2019 through relaunch in February 2024, including valuable insights into their program development and implementation.

University of Michigan Health piloted their HCAH program in coordination with Blue Cross Blue Shield Commercial, and then expanded payer coverage to Medicare once the Centers for Medicare & Medicaid (CMS) established the Acute Hospital Care at Home Waiver during the COVID-19 pandemic. The intent for the HCAH program was to alleviate significant capacity issues within the brick-and-mortar hospital. By reviewing inpatient cases that met specific HCAH criteria, patients were able to continue necessary inpatient care at home while hospital beds were made available for more acute care needs.

Due to logistical and management barriers, the HCAH program decided to partner with an external vendor, Medically Home, in late 2023 to meet the needs of their patients and provide more in-home inpatient care and services. This vendor manages a 24/7 care team model, including a virtual hospitalist team, while providing services such as mobile diagnostics (e.g., X-ray, ultrasound), paramedicine, STAT labs and IV, and offering pathways to in-hospital services such as MRI or CT scans (Figure 1).

The HCAH program has seen a maximum daily census of 10 patients and has an average length of stay of approximately 4 days. Patients who participated in the program had a lower 30-day readmission rate (17%) compared to patients who stayed in the hospital (20-24%). This correlates with a recent report from CMS on HCAH service data showing reduced 30-day readmission rates in most of the associated diagnosis related groups (DRGs) (Centers for Medicare & Medicaid Services, 2024) and is a promising trend for future program development.

One of the challenges the HCAH program faced was engaging providers in utilizing the at-home inpatient service. One proposed solution is to offer education and useful tools within the EPIC medical record, allowing providers to track which patients meet eligibility criteria and make appropriate referrals to the program. Additionally, once providers are educated on the HCAH program, they can share and educate their patients about this care option. By continuing to engage and educate providers and patients, the HCAH program anticipates continued expansion, with a goal to cover a broader patient population with increased payer coordination.

October Sepsis Workgroup: Garden City Hospital

The second October workgroup focused on sepsis, one of MVC’s value metrics within the MVC Component of the BCBSM P4P Program. This workgroup featured a presentation by Akhil Vijay, Director of Quality Assurance and Performance Improvement at Garden City Hospital. Vijay’s presentation reviewed Garden City Hospital’s sepsis care program, sharing their development process and progress since the program’s implementation.

Following CMS and the Joint Commission's Sepsis Core Measure launch in 2015, Garden City Hospital has worked to build an effective sepsis care program reflective of all core elements (Figure 2). Starting in February 2024, their sepsis compliance rate was approximately 46%. After meeting with leadership, a root cause analysis was completed to determine why the compliance rate was low compared to the national average. Building a partnership between leadership and providers proved to be a key strategy for successfully establishing weekly quality meetings to review sepsis cases and identify patterns of fallouts.

The quality team developed several methods for engaging leadership and providers in the program, such as:

developing an interdisciplinary sepsis committee to review cases,
following a standardized approach for case review with action plan development,
presenting sepsis cases at weekly didactic resident physician meetings,
and attending rounds with an infection prevention specialist to educate providers.

In addition to making this case education more visible in providers’ daily work, the program shared sepsis case scorecards with providers highlighting successes and areas for improvement. This in turn motivated the healthcare team to engage in friendly competition to achieve the best results.

Since January 2024, Garden City Hospital has improved its sepsis compliance, going from approximately 45% in January to a monthly average of approximately 63% by September 2024.

If you are interested in pursuing a sepsis care improvement program, MVC has a robust registry of medical insurance claims data that can be utilized as well as data specialists to help navigate and create custom analytic reports. Please reach out to the Coordinating Center [email] if you would like to learn more about MVC data or engagement offerings.

To learn more about the efforts showcased by University of Michigan Health, Garden City Hospital, or other past workgroup presentations, visit MVC’s YouTube channel here.

November’s workgroups include a preoperative testing presentation that occurred Nov. 5 with a presentation by Pam Racchi, BSN, RN, Clinical Site Coordinator with the Michigan Surgical Quality Collaborative. MVC will also host a cardiac rehabilitation workgroup on Nov. 21. You can view the complete 2024 and 2025 event calendars here.

30 Oct 2024

collaborative-wide meeting MVC Coordinating Center quality improvement

View Post

MVC Fall 2024 Meeting Summary: Data-Driven Strategies for Success in Quality Improvement

October 30, 2024 | 0 Comments | collaborative-wide meeting, MVC Coordinating Center, quality improvement

The Michigan Value Collaborative (MVC) held its fall 2024 collaborative-wide meeting on Fri., Oct. 25, in Livonia. A total of 99 attendees representing 54 hospitals, 6 physician organizations, 2 Collaborative Quality Initiatives (CQIs), and 8 healthcare systems from across the state of Michigan came together to discuss innovative approaches to data-driven quality improvement. The theme of this meeting was to provide MVC members with new data use strategies to support their QI initiatives.

MVC program manager Erin Conklin, MPA, kicked off Friday’s meeting with an update from the MVC Coordinating Center [SEE SLIDES]. She welcomed MVC’s newest team member, site engagement coordinator Rachel Folk, MHA. Conklin also announced phase 2 of recruitment for the RITE-Size preoperative testing initiative, and provided details for the Michigan Cardiac Rehab Network (MiCR) meeting planned for Fri., Nov. 8 in Midland [register here by 10/31]. She concluded by highlighting recent MVC reporting, including refreshed versions of MVC’s common conditions and procedures push reports, a new statewide diabetes report, PY 2024 P4P mid-year scorecards, and MVC’s 3^rd annual QECP public report.

Senior Advisor Jim Dupree, MD, MPH, presented on the MVC Component of the BCBSM P4P Program [SEE SLIDES]. He reviewed MVC’s guiding principles, timeline, and historical program structure, announcing four key changes to the PY 2026-2027 cycle (Figure 1). The addition of a health equity measure is one of four key areas that MVC modified for the upcoming cycle.

The first change that Dr. Dupree discussed in detail is the change to MVC’s payer mix for PYs 2026/2027. Since April 2023, MVC members were given access to rates and spending for their Medicaid patients. Adding this patient population to the MVC P4P payer mix allows the collaborative to score a more comprehensive and diverse patient population. Medicaid data will be reflected in baseline measures provided in MVC participants’ PYs 2026/2027 selection reports.

Dr. Dupree also announced changes to the P4P episode payment condition menu for PYs 2026/2027. MVC will retire colectomy, pneumonia, and joint replacement, and will add percutaneous coronary intervention (PCI). Dr. Dupree summarized MVC’s decision-making and rationale behind each retirement or addition. As a result of these changes, the episode spending metric options for the upcoming cycle include CABG, CHF, COPD, and PCI.

A third change announced on Friday was a revision to the definition of MVC’s sepsis value metric. Dr. Dupree explained that this adjustment was being made to align with the Michigan Hospital Medicine Safety Consortium (HMS) initiative to increase post-discharge care coordination after sepsis. In PYs 2026-2027, MVC’s sepsis value metric will change from 30-day risk-adjusted readmissions after sepsis to 14-day follow-up after sepsis.

To close out the P4P presentation, Dr. Dupree announced the inclusion of a new health equity measure and the methodology behind it. This measure was developed with the goal of addressing common barriers that MVC member hospitals reported in the MVC health equity survey, such as insufficient data, no clear business case, and insufficient financial investments. With the introduction of MVC’s P4P health equity measure (Figure 2), MVC wants to quantify and drive improvement in all-cause readmission rates between payer groups at each hospital using an index of disparity (IOD). Dr. Dupree explained that similar index or composite measures have been utilized by health organizations already, and that this risk-adjusted measure can help identify hospital-level preventable differences in readmissions. Hospitals will earn the health equity point by improving relative to their own baseline IOD or by performing well relative to their peers (i.e., having an IOD at or below the median IOD across the collaborative).

Before closing the P4P session, Dr. Dupree reviewed the upcoming P4P timeline for various cycles. MVC selection reports for PYs 2026/2027 will be shared with members in early November. Following dissemination of these selection reports, MVC will accept selections until Dec. 13, 2024. Members may attend one of two webinars on Nov. 19 at 1 p.m. [REGISTER for 11/19] or Nov. 21 at 10 a.m. [REGISTER for 11/21] to support their selection process, as well as schedule one-on-one meetings with MVC staff as needed.

After the P4P session, MVC members and stakeholders presented posters highlighting their QI work on a wide variety of conditions and initiatives (Figure 3). The MVC Coordinating Center would like to thank all poster presenters for sharing their work. Electronic copies of the posters are available on the MVC website [LINK].

The poster session was followed by a presentation from the vice president of care coordination for Corewell Health System, Tricia Baird, MD, FAAFP, MBA. Dr. Baird leads inpatient, transitional, and ambulatory care coordination teams comprised of registered nurses, social workers, and community health workers. The presentation, “Readmission Reduction: Intelligent Targeting to Timely Intervention,” provided an in-depth look at how Dr. Baird’s team identified a subset of their Medicare patients with readmissions that were preventable [SEE SLIDES]. After identifying their complex patients, the Corewell team then designed interventions to target those discharge journeys, essentially providing an example of how to lower a payer-specific readmission rate.

After a networking lunch, attendees spent the afternoon participating in breakout sessions on two topics of their choice. A cardiac rehabilitation breakout session was led by Jodi Perdue, RN-C, BSN, who presented on Munson Medical Center’s multi-phase cardiac rehabilitation program [SEE SLIDES]. Her session was followed by an MVC unblinded data presentation by MVC site engagement coordinator Emily Bair, MS, MPH, RDN.

In the post-discharge follow-up breakout session, MVC project manager Jana Stewart, MS, MPH, guided attendees through a patient journey mapping workshop [SEE SLIDES]. Attendees learned the basics of patient journey mapping approaches and collaborated to draft patient journey maps for key patient populations in Michigan.

In the preoperative testing breakout session, Dana Green, Jr., MPH, a project manager and de-implementation specialist for the Michigan Program on Value Enhancement (MPrOVE), educated attendees on available resources, lessons learned, and upcoming opportunities related to the RITE-Size initiative [SEE SLIDES]. MVC engagement manager Jessica Souva, MSN, RN, C-ONQS, then showed participants their own sites’ performance on MVC’s preoperative testing metric using unblinded data.

The fourth breakout session on sepsis was led by Pat Posa, RN, BSN, MSA, CCRN, FAAN, a quality and patient safety program manager with the Michigan Hospital Medicine Safety Consortium (HMS). She outlined the complex impact of sepsis on patients and the motivations behind launching the HMS Sepsis Initiative, as well as details about HMS sepsis bundles and performance data [SEE SLIDES]. The session was closed out by MVC senior analyst Kim Fox, MPH, with an unblinded data presentation on 14-day follow-up after sepsis, MVC’s newest value metric.

The meeting closed with reminders about upcoming meetings, key dates for the PY 2026-2027 P4P metric selection process, and post-event survey information presented by Jessica Souva (Figure 4).

23 Oct 2024

MVC P4P

View Post

Hospitals Receive PY24 Mid-Year Scorecards for MVC Component of BCBSM P4P Program

October 23, 2024 | 0 Comments | MVC P4P

Last week the Michigan Value Collaborative (MVC) distributed mid-year scorecards for Program Year (PY) 2024 of the MVC Component of the Blue Cross Blue Shield of Michigan (BCBSM) Pay-for-Performance (P4P) Program. This report provided hospitals with their current standing for PY 2024.

Each hospital received a mid-year score out of a total of 10 points, including 0 to 4 points for their selected total episode payment metric, 0 to 4 points for their selected value metric, and 0 to 2 points for completed eligible engagement activities thus far in calendar year 2024. PY 2024 scores achievement and improvement points for each hospital’s selected episode spending conditions and value metrics using index admissions from 2023 as the performance year against admissions in 2021 as the baseline year. Hospitals are awarded the higher of their achievement and improvement point scores.

The performance data timeframes included in mid-year PY 2024 scoring were index events 1/1/2023-12/31/2023 for BCBSM PPO Commercial, BCBSM Medicare Advantage, BCN HMO Commercial, and BCN HMO MA, and index events 1/1/2023-9/30/2023 for Medicare FFS. The engagement points accrued represent all completed activities from 1/1/2024-9/30/2024. This is the first year of a two-year (PY24-25) P4P cycle. The full methodology for this program cycle can be found in the PY2024-2025 technical document.

Figure 1 illustrates the current distribution of total points out of 10 across the collaborative. The average points scored across the mid-year scorecards was 6.2/10. This average is 0.2 points lower than the average points scored at the conclusion of PY23.

Figure 3 illustrates the breakdown of average points by episode spending condition. Consistent with previous years, joint replacement was the highest scoring condition with an average of 3.1 points. Much of the recent success observed for the joint replacement condition could be attributed to the shift from post-acute care in skilled nursing facilities (SNF) to home health and the move towards outpatient surgeries; however, with most joint replacements now occurring in outpatient settings there is less savings to be achieved from such shifts going forward. Congestive heart failure and pneumonia were the lowest scoring conditions with hospitals earning less than two points on average for each.

Figure 4 illustrates the breakdown of average points by value metric. The highest scoring value metric was preoperative testing with 3.4 points followed by 90-day cardiac rehab utilization after percutaneous coronary intervention (PCI) with 2.8 points. For both of these value metrics, hospitals have access to additional support and resources via MVC’s value-based improvement initiatives, including the RITE-Size (Right-Sizing Testing before Elective Surgery) initiative and the Michigan Cardiac Rehab Network (MiCR) offerings. The lowest scoring value metric was 7-day follow-up rates after pneumonia (2.1).

These mid-year P4P scores are subject to change as new data is added. The final scorecards will be distributed after all 2023 claims are incorporated. Hospitals can track their score through the P4P PY24-25 reports on the MVC registry, which provides all relevant scoring information for both improvement and achievement points in one place. These registry reports can be filtered by selected conditions/metrics to make the tracking of P4P points easier. Contact the MVC Coordinating Center [EMAIL] for a walkthrough of your hospital’s PY24 mid-year scorecard or P4P registry reports.

16 Oct 2024

BCBSM P4P MVC P4P

View Post

New Qualitative Analysis Offers Insights on How Hospitals Approach MVC P4P Program

October 16, 2024 | 0 Comments | BCBSM P4P, MVC P4P

Quality improvement is critical for ensuring that healthcare services are safe, efficient, patient-centered, and equitable. As such, payers have increased their reliance on financial incentives to encourage high performance, foster improvement, and promote accountable spending. Despite the saturation of studies assessing hospital approaches to federal incentive programs, there remains a lack of information surrounding hospitals’ strategies for episode-based reimbursement in commercial payment models.

Blue Cross Blue Shield of Michigan’s (BCBSM) Hospital Pay-for-Performance (P4P) Program rewards hospitals that excel at care quality, cost-efficiency, and population health management. In 2018, BCBSM partnered with the Michigan Value Collaborative (MVC) in allocating 10% of its P4P program budget to an episode of care spending metric based on MVC data.

To fill the knowledge gaps mentioned above, a qualitative analysis published earlier this year in the American Journal of Managed Care (AJMC) [LINK] took advantage of a unique opportunity to explore hospital activity and decision-making within MVC’s episode-based incentive program. The lead author of the resulting publication was MVC Senior Faculty Advisor Dr. Scott E. Regenbogen, MD, MPH, who previously served as a Co-Director of MVC. In engaging with MVC’s hospital members, the project team aimed to understand hospital approaches to commercial incentive programs, identify best practices for success, and collect information to promote the optimal design of future metrics.

In an effort to understand the variability between participating hospitals, qualitative interviews were completed with 21 leaders from 8 intentionally selected hospitals with ranging performance metrics. Between December 2020 and November 2021, administrative leaders and quality officers were interviewed using a video teleconference-based platform. Each interview followed a standardized protocol and addressed four domains: choice of clinical condition for evaluation, strategies for episode spending reduction, best practices for success in learning incentives, and barriers to achievement.

Clinical Condition Selection Approaches

When asked about approaches to selecting clinical conditions, besides programmatic constraints, the project team found that multiple factors impacted hospitals’ decisions. Throughout the selection process, many hospital leaders aimed to identify opportunities for improvement or areas of historic underperformance.

In analyzing this trend, Dr. Regenbogen commented, “We were somewhat surprised that there was less ‘playing to the test’ than expected. For the most part, hospitals were committed to success in this program and made good faith efforts to try and achieve savings through operational improvements, not just making the numbers look good.” In addition to seeking opportunities for the greatest improvement, participants selected conditions that often aligned with ongoing value-based improvement efforts, especially those related to federal value-based financial incentive programs. A final factor contributing to the selection approach for many sites was the commitment and motivation of physician leaders to contribute to quality improvement. Most site coordinators agreed that without individual and collective dedication to hospital-based initiatives, success was unlikely.

Strategies for Episode Payment Improvement

As members of MVC, the participants in this analysis had access to comprehensive utilization data and risk-adjusted comparisons with other hospitals across the state of Michigan. When asked about methods to improve performance, site coordinators highlighted the immense benefits of MVC’s custom analytic and annual push reports, citing the utilization of administrative and clinical data to motivate and inspire improvement at their respective hospitals. In addition to using MVC data to identify areas of growth, respondents also recognized the importance of standardizing protocols and policies to promote the implementation of consistent best practices.

Best Practices for Success in the Incentive Program

In discussing the strategic approaches of program participants, hospitals highlighted three main areas of importance regardless of their performance rank: consistent leadership focus on metrics, readmissions reduction, and controlling costs related to post-acute care.

Obstacles to Success

However, despite these similar strategic approaches, low-performing participants also noted obstacles and barriers to their success in the program. One institution noted a failure to remain focused on cost containment for a condition across the measurement period, while another expressed a disconnect between institutional achievement goals and non-employed physician incentives. In response to participants’ obstacles to engaging with physicians, co-author and MVC Senior Advisor Mike Thompson, PhD, MPH, who served as MVC’s most recent Co-Director until June 2024, noted, “Perhaps it isn’t surprising, but the challenge of engaging front-line clinicians in pay-for-performance programs is always difficult. Bridging the gap between broader administrative goals and daily clinical operations can sometimes feel like a canyon, but it is necessary for success.”

Implications for the Future

Altogether, the data collected during the qualitative arm of this analysis gleaned key quality improvement insights that MVC can utilize to inform the continued refinement and improvement of the MVC Component of the BCBSM P4P Program. The project team posits that, to be successful, these incentives must possess enough depth and relevance to capture the attention of hospital leadership or align closely with larger initiatives to facilitate collaboration; they must address and resolve any discrepancies between the goals of the hospital and the incentives driving credentialed physicians; and, most importantly, commercial episode-based incentives should offer the chance for success by delivering not only initial performance enhancements but also consistently maintaining excellence over time.

Moving forward, continued program evaluation will be crucial for understanding how to best design metrics in the pursuit of high-value, equitable healthcare. This area of investigation opens the door to future insights into the relationship between financial incentives and quality improvement in healthcare, holding vast potential to shape future incentive-based measures and reporting. As such, MVC is committed to understanding and improving the effectiveness of its own incentive-based measures in partnership with BCBSM.

To learn more about MVC offerings and the MVC Component of the BCBSM P4P Program, please visit our website or contact us at Michigan-Value-Collaborative@med.umich.edu.

02 Oct 2024

COPD health equity MVC workgroup post-discharge follow-up rural health

View Post

September MVC Workgroups Highlight Initiatives for COPD Readmissions, Health Equity

October 2, 2024 | 0 Comments | COPD, health equity, MVC workgroup, post-discharge follow-up, rural health

Since its founding, a core component of MVC’s strategy has been organizing opportunities to collaborate with and learn from peers, leading to the ongoing facilitation of MVC workgroups. MVC has hosted workgroup presentations twice per month in recent years, and this year’s workgroups are focused on six topic areas: post-discharge follow-up, sepsis, cardiac rehabilitation, rural health, preoperative testing, and health in action. Going forward, MVC will publish a monthly blog to highlight key takeaways and shared resources from the prior month’s presentations. In doing so, all MVC members and partners may utilize and benefit from the content regardless of their live participation.

September Post-Discharge Follow-Up Workgroup

MVC hosted a post-discharge follow-up workgroup on Sept. 10 featuring a presentation by Brian Leideker, RRT, COPD Navigator for Trinity Health Oakland Hospital. Leideker’s presentation summarized Trinity Heath Oakland Hospital’s progress since initiating an A3 COPD readmission committee in June 2021, including the key interventions their team has implemented to date.

One initial intervention was the hiring of a COPD navigator. Leideker described how his unique role as a respiratory therapist involved in case management has allowed him to be “a middleman between respiratory physicians and other entities trying to deliver and support services” for COPD patients.

Following several root cause analyses, the COPD committee identified that nearly 90% of patients readmitted for COPD at Trinity Health Oakland Hospital had an interruption in intended continuation of pharmacotherapy and/or non-pharmacotherapy treatments. This finding encouraged Leideker’s team to work to improve the education of patients, providers, and the greater healthcare community on ambulatory treatment for COPD as well as reviewing the testing and documentation needed to ensure coverage of durable medical equipment (DME) post-discharge.

With the help of an MVC custom analytic report, Leideker was able to trend DME utilization rates for patients hospitalized with COPD since the initiation of these interventions, as seen in Figure 1.

Generally, the utilization rate of post-discharge non-bi-level home ventilators (E0466) was found to increase over time, while bi-level home ventilator (E0470) utilization has decreased. Leideker noted that this was somewhat expected since patients routinely report difficulty with the utilization of bi-level home ventilators (BiPAP) and often move on to non-bi-level home ventilators (CPAP). Additionally, based on Trinity Health Oakland’s internal analyses as of May 2024, their COPD three-day readmission rates have been reduced to <18% for all payers.

September Rural Health Workgroup

MVC hosted a rural health workgroup on Sept. 26 featuring a presentation by Brent Mikkola, MBA, PMP, Manager of Community Health at MyMichigan Health. Mikkola’s presentation summarized MyMichigan Health’s approach to developing a strategic plan for health equity and an overview of some specific community programs currently in place. MyMichigan Health’s phased approach to integrating health equity is currently focused on evaluating social determinant of health (SDoH) opportunities in an “assess, analyze, and address” model.

Some unique community partnerships that resulted from this process include:

Gratiot County Public Transit voucher program
Rx 4 Health – partnership with Michigan State Extension and specific grocery suppliers including SpartanNash, SaveALot, and Meijer
Food Pharmacies & Weekend Kits - partnership with the Greater Lansing Food Bank and the Food Bank of Eastern Michigan
Bridge to Belonging - virtual series on loneliness and social connection
Continuing Care Clinic Pilot with Community Health Workers (CHWs)
Intervention for Nicotine Dependence: Education, Prevention, Tobacco and Health (INDEPTH) Suspension Diversion Program

In addition to developing a strategic framework for reporting and developing objectives around health equity, Mikkola described how MyMichigan Health delved into the data collection, analysis, and quality improvement work surrounding health equity. For example, after initially integrating CHWs into community practices and inpatient services, MyMichigan Health further integrated CHWs following the WHO’s CHW Lifecycle Approach, as seen in Figure 2.

To learn more about the efforts showcased by Trinity Health Oakland and MyMichigan Health, or to view past workgroup presentations, visit MVC’s YouTube channel here.

October’s workgroups will include a health in action presentation on Oct. 8 about the University of Michigan’s Hospital Care at Home program, as well as a sepsis presentation on Oct. 17 by Garden City Hospital. You can view the complete 2024 calendar of events and register for workgroups here. To learn more about MVC workgroups or other presentation opportunities, contact the MVC Coordinating Center by emailing us here.

24 Sep 2024

CQIs diabetes mct2d michigan MVC Push Reports Type 2 diabetes

View Post

MVC, MCT2D Introduce New State-of-the-State Report on Type 2 Diabetes in Michigan

September 24, 2024 | 0 Comments | CQIs, diabetes, mct2d, michigan, MVC Push Reports, Type 2 diabetes

Chronic disease management was a key driver of healthcare utilization over the last decade and has been cited as the most expensive chronic disease in the U.S. In response, MVC recently partnered with the Michigan Collaborative for Type 2 Diabetes (MCT2D) to develop a statewide report on Type 2 Diabetes (T2D), a chronic illness that impacts over 1 million adults in Michigan. This new report was recently shared by both MVC and MCT2D at the Michigan Obesity Summit and will be distributed to MVC member hospitals later this week.

The report summarized demographics, healthcare utilization, and prescription patterns among those patients with T2D in Michigan insured by Blue Cross Blue Shield of Michigan (BCBSM), Blue Care Network (BCN), Medicare Fee-for-Service (FFS), and Michigan Medicaid between 2017 and 2023. To create this report, MVC first used its claims data to identify beneficiaries aged 18 and older with a qualifying T2D diagnosis in the past year. After identifying annual cohorts of beneficiaries with T2D for each year, 2017-2023, MVC assessed annual utilization of T2D prescription medications, emergency department (ED) visits, inpatient hospitalizations, and provider visits.

MVC assessed filled prescriptions among T2D beneficiaries with corresponding prescription coverage using its pharmacy claims. This was the first time MVC included prescription claims data in a member push report and the first time that prescription claims from all MVC payer sources were utilized in a single MVC analysis. Medicare beneficiaries were excluded from 2022 and 2023 prescription utilization rates because Medicare pharmacy claims were only available through 12/31/2021. Diabetes-related drug classes were identified in pharmacy claims based on National Drug Code (NDC) as well as standardized prescription names and classes.

Newer medications such as GLP-1 receptor agonists and SGLT2 inhibitors are frequently prescribed to improve glucose control, reduce mortality, slow kidney disease progression, and aid in weight loss. The American Diabetes Association now recommends the use of these medications for patients with cardiovascular disease, kidney disease, and obesity. In keeping with these guidelines, MVC’s analyses indicated a large increase in utilization of GLP-1 receptor agonists (3.1% to 18.6%) and SGLT2 inhibitors (2.3% to 14.2%) between 2017 and 2023 (Figure 1). In the same period, prescriptions decreased from 2017 to 2023 for insulins (20.9% to 16.5%) and sulfonylureas (17% to 10.9%).

Demographic characteristics including age, sex, race (Figure 2), and insurance provider (payer) were described within the report for all beneficiaries with T2D across all payers 2017-2023 and compared to the characteristics of all beneficiaries reflected in MVC data during those years. Compared to all beneficiaries, those with T2D were older, with an average age of 66 years versus the average of 43 years among all beneficiaries. T2D beneficiaries were also more likely to be male (50% vs 43%), Black (20% vs 15%), and more often covered by non-commercial insurance plans (45% vs 28%).

This new report created in partnership with MCT2D provided a high-level overview of healthcare utilization among T2D beneficiaries within Michigan. Since the analyses utilized data derived from medical insurance claims, one key limitation was the exclusion of uninsured individuals as well as key indicators of T2D outcomes that are not accurately captured in claims data, such as HbA1C levels, blood pressure, continuous glucose monitor utilization, and retinopathy screening. Despite these gaps, the data revealed promising trends in diabetes care, including increased primary care visits, greater use of guideline-directed medications proven to show significant benefit, and reduced emergency department visits. MVC’s analyses also underscored areas for improvement, such as the need to address health equity gaps and continued promotion of guideline-directed medical therapy.

MVC will share copies of the completed report directly with members later this week, and a copy is also available on the MVC website [PDF]. If you are interested in pursuing a custom analysis for any of these measures or a different tailored custom analysis, please reach out to MVC.

November Preoperative Testing Workgroup: Michigan Surgical Quality Collaborative (MSQC)

Figure 1.

Figure 2.

November 5 Preoperative Testing Workgroup

November Cardiac Rehab Workgroup: Marshfield Medical Center – Dickinson

Figure 3.

November 21 Cardiac Rehab Workgroup

Figure 1. Yearly Rates of ED Utilization Among T2D Beneficiaries, 2017-2023

Figure 2. Yearly Rates of Provider Visit Utilization Among T2D Beneficiaries by Provider Type

Figure 3. T2D Medication Utilization Among Beneficiaries with T2D, 2017-2023

Figure 1.

Figure 2.

Figure 3.

October Health in Action Workgroup: University of Michigan Health

Figure 1.

Oct. 8 Heath in Action Workgroup

October Sepsis Workgroup: Garden City Hospital

Figure 2.

Figure 3.

Oct. 17 Sepsis Workgroup

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 1. Annual Select* DME Utilization Rates During the Index and 30-Day Post-Discharge Period Among Patients Hospitalized for COPD at Trinity Health Oakland (2020-2023)**

Sept. 10 Post-Discharge Follow-Up Workgroup

Figure 2.

Sept. 26 Rural Health Workgroup

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Subscribe to our blog!

Recent Posts

Categories

Contact Us

Mission

Site Map